Cannabis News
Authoritative coverage of the global cannabis industry — regulation, investment, markets and policy, reported for the people who run it.
Cannabis News · page 64
- CBD Market
UK CBD Business Sues Government for £3.4m Over ‘Unlawful’ Seizure of Hemp
The UK Government is being sued by a CBD business for £3.4m, in the latest major challenge to its mishandling of legal hemp.
- Companies
Cannabis Industry Giants Merge to Form Unified Advocacy Group in Washington
Two of the US’ biggest cannabis industry groups have joined forces, aiming to amplify the collective voice of nearly half a million employees as a new government administration is sworn in.
- Opinion
Canexis Pharma: Setting the Standard for Purity in Medical Cannabis
Ahead of the release of Prohibition Partners upcoming Global Cannabis Report: 5th Edition, we sat down with Sebastian Zeller, Managing Director of Canexis Pharma AG, a Swiss-based leader in medical cannabis production.
- Markets & Stocks
High Tide Breaks into German Market, Cantourage Exceeds Projections in 2024, & More from SEED
Cantourage [stock_market_widget type=”chart” template=”line” assets=”HIGH.DE” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Berlin-based medical cannabis company Cantourage saw sales exceed its own projections in 2024, with sales more than doubling on 2023.
- Hemp Industry
DoorDash Begins Delivering CBD and Intoxicating Hemp Products
US store-to-door delivery giant DoorDash announced last week that it will begin offering CBD and intoxicating hemp substances through its service in response to growing demand.
- Medical
First Products Registered in Ukraine by Curaleaf Ahead of Medical Cannabis Rollout
The first medical cannabis products have officially been registered in Ukraine, meaning patients should be able to access treatment in the coming weeks.
- Uncategorized
Cannabis debt crisis looms as billions in loans come due in 2026
As much as $3 billion in debt will come due for major U.S. cannabis operators by the end of 2026, a “wave” of maturities that could portend a significant shake-up in the regulated industry.
- Uncategorized
Cannabis Rescheduling Hearing Delayed Amid Escalation of Tensions Between DEA and Other Witnesses
The highly anticipated hearings on cannabis rescheduling, set to begin next week, have now been cancelled in a major escalation of tensions between the Drug Enforcement Administration (DEA) and other witnesses.
- Press releases
SOMAÍ Pharmaceuticals Expands to Thailand With New PACCAN Partnership
SOMAÍ Pharmaceuticals, a leading EU-GMP vertically integrated Multi-Country Operator (MCO) with the most advanced cannabinoid pharmaceutical extract portfolio, has partnered with Pacific Cannovation Company Limited (PACCAN) to transform Thailand into a global hub for high-quality medicinal cannabis.
- Uncategorized
New York Cannabis Licence Approvals Hampered as More Lawsuits Stack Up
New York’s adult-use cannabis market continues to be mired in controversy and new legal disputes despite topping $1bn in sales last year.
- Cultivation
What Could Trudeau’s Exit Mean for Cannabis in Canada?
Canada’s Prime Minister, Justin Trudeau, announced last week that he plans to step down as leader of the Liberal Party amid growing internal pressure and falling approval ratings.
- Uncategorized
Cannabis Stocks Fall as DEA Ordered to Respond to Bias Allegations
Cannabis stocks plummeted this week after a judge ordered the Drug Enforcement Agency (DEA) to respond to damning new allegations that it is working to undermine the cannabis rescheduling process.
